Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

Presentation ESC 2025

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Presenter: David Newby

September 03, 2025

Presentation ESC 2025

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Presenter: Anders Jeppsson

September 01, 2025

Presentation ESC 2025

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Presenter: Pedro A. Lemos

August 30, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News ESC 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Michael O'Riordan

August 30, 2023

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

Caitlin E. Cox

September 06, 2022

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

Todd Neale

August 24, 2021

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

Presentation ESC 2019

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Presenter: Johannes Neumann

September 01, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

Presentation ESC 2019

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Presenter: David B. Brieger

September 01, 2019

News Conference News ESC 2019

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Michael O'Riordan

August 31, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Conference News ESC 2018

Myocardial Injury or MI? New Universal Definition Aims for Clarity

Todd Neale

September 05, 2018

Advertisement

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

CV Care Around Noncardiac Surgery: New ESC Guidelines

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Myocardial Injury or MI? New Universal Definition Aims for Clarity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content